Menlo Park-based Deltagen Inc. has secured $10 million in capital through an equity investment by Dr. George B. Rathman, the chairman and chief executive officer of Sunnyvale's Hyseq Inc.
The agreement, which Deltagen secured through the sale of 1.5 million shares of its common stock, also calls for the two biotechnology firms to collaborate on research that could produce genom...
The agreement, which Deltagen secured through the sale of 1.5 million shares of its common stock, also calls for the two biotechnology firms to collaborate on research that could produce genom...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In